Panelists at a recent pharmacy conference were optimistic about the future of value-based drug contracting. For example, one said that healthcare will be close to establishing a value-based formulary by 2030, and another said that longitudinal patient tracking will become a more important part the drug pricing process.
/PRNewswire/ Asieris Pharmaceuticals (688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs.
Dublin, July 15, 2022 (GLOBE NEWSWIRE) The "Asia Pacific Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems,.